Abstract:Background: DL-3-n-butylphthalide (NBP) was demonstrated to increase the cerebral blood flow (CBF) in the animal models, but there are no clinic studies to verify this. We aimed to explore the effect of NBP on improving cerebral hypoperfusion caused by cerebral large-vessel stenosis. Methods: In this single-center, randomized, double-blind, placebo-controlled study, 120 patients with severe carotid atherosclerotic stenosis and cerebral hypoperfusion in the ipsilateral middle cerebral artery (MCA) were included and randomly assigned into NBP or placebo group as 1:1 radio. Patients in NBP or placebo group received 200 mg or 20 mg of NBP capsules three times daily for four weeks respectively. Single photon emission computed tomography (SPECT) was used to assess regional CBF (rCBF) in four regions of interest (ROIs) corresponding to MCA before and 12 weeks after the treatment. After therapy, the rCBF change for every ROI and the whole CBF change in MCA territory for every patient were classified into amelioration, stabilization and deterioration respectively. Results: 48 NBP patients (6 with bilateral stenosis) and 46 placebo patients (8 with bilateral stenosis) completed the trial. Overall, both groups had 54 stenotic carotid arteries and 216 ROIs for rCBF change analysis. After therapy, the rCBF in ROIs increased in NBP group (83.5% ± 11.4% vs. 85.8% ± 12.5%, p = 0.000), whereas no change was found in placebo group (86.9% ± 11.6% vs. 87.8% ± 11.7%, p = 0.331). Besides, there was higher percentages of ROIs with rCBF amelioration and stabilization in NBP group than in placebo group (93.1% vs. 79.2%, p = 0.000). Furthermore, ordinal regression analysis showed that compared with placebo, NBP independently made more patients to have whole CBF amelioration in ipsilateral MCA (Wald-χ2 = 5.247, OR = 3.31, p = 0.022). Conclusions: NBP might improve the cerebral hypoperfusion in the patients with carotid artery atherosclerotic stenosis. Trial registration: Chinese Clinical Trial Registry, ChiCTR1900028005, registered December 8th 2019- Retrospectively registered (http://www.chictr.org.cn/index.aspx).

Dl-3-N-butylphthalide Attenuates Ischemic Reperfusion Injury by Improving the Function of Cerebral Artery and Circulation

DL-3n-Butylphthalide Improves Blood–Brain Barrier Integrity in Rat After Middle Cerebral Artery Occlusion

DL-3-n-butylphthalide Attenuates Cerebral Ischemia-Reperfusion Injury by Inhibiting Mitochondrial Omi/HtrA2-Mediated Apoptosis

Effects of Dl-3N-butylphthalide on the Expression of VEGF and Bfgf in Transient Middle Cerebral Artery Occlusion Rats

Enhanced Angiogenesis with Dl-3N-butylphthalide Treatment after Focal Cerebral Ischemia in RHRSP

Dl-3-n-butylphthalide Inhibits Neuroinflammation by Stimulating Foxp3 and Ki-67 in an Ischemic Stroke Model.

The protective effect of dl-3n-butylphthalide on local cerebral ischemia-reperfusion injury in experimental rats

Antineuroinflammatory Effects of Dl-3-n-butylphthalide Conferred by Stimulation of Foxp3 and Ki-67 in an Ischemic Stroke Model

Effects of Dl-3-n-butylphthalide on Expression of VEGF and Bfgf in Rat Brain with Permanent Focal Cerebral Ischemia

DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress

Dl-3-n-butylphthalide attenuates cerebral ischemia/reperfusion injury in mice through AMPK-mediated mitochondrial fusion

L-3-n-butylphthalide Promotes Restoration after an Experimental Animal Model of Intracerebral Hemorrhage.

Dl-3N-butylphthalide Prevents Stroke Via Improvement of Cerebral Microvessels in RHRSP.

L-3-n-butylphthalide Attenuates Inflammation Response and Brain Edema in Rat Intracerebral Hemorrhage Model.

l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats.

Vascular protection and regenerative effects of intranasal DL-3-N-butylphthalide treatment after ischaemic stroke in mice

DL-3-n-Butylphthalide Ameliorates Post-stroke Emotional Disorders by Suppressing Neuroinflammation and PANoptosis

Effects of Dl - 3 - N - Butylphthalide on Expression of Bcl - 2 in Rat Brain after Cerebral Ischemia/reperfusion Injury

Efficacy and Safety of 3-N-butylphthalide Combined with Endovascular Treatment in Acute Ischemic Stroke Due to Large Vessel Occlusion.

Dl-3-n-butylphthalide Improves Functional Recovery in Rats with Spinal Cord Injury by Inhibiting Endoplasmic Reticulum Stress-Induced Apoptosis.

DL-3-n-butylphthalide improves cerebral hypoperfusion in patients with large cerebral atherosclerotic stenosis: a single-center, randomized, double-blind, placebo-controlled study